Literature DB >> 28619212

Treatment of preschool children for schistosomiasis.

Antonio Montresor1, Amadou Garba2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28619212     DOI： 10.1016/S2214-109X(17)30202-4

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  10 in total

Review 1.  Paediatric schistosomiasis: What we know and what we need to know.

Authors:  Derick N M Osakunor; Mark E J Woolhouse; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2018-02-08

2.  A prospective risk assessment of the implementation of a schistosomiasis preventive mass drug administration for children aged five years and below in the uMkhanyakude district of KwaZulu-Natal.

Authors:  Mhlengi Vella Ncube; Moses John Chimbari
Journal:  BMC Health Serv Res       Date:  2019-10-07       Impact factor: 2.655

3.  Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination.

Authors:  Klodeta Kura; James E Truscott; Jaspreet Toor; Roy M Anderson
Journal:  PLoS Negl Trop Dis       Date:  2019-06-05

4.  Differential impact of mass and targeted praziquantel delivery on schistosomiasis control in school-aged children: A systematic review and meta-analysis.

Authors:  Danielle M Cribb; Naomi E Clarke; Suhail A R Doi; Susana Vaz Nery
Journal:  PLoS Negl Trop Dis       Date:  2019-10-11

5.  Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni.

Authors:  Klodeta Kura; Diepreye Ayabina; T Deirdre Hollingsworth; Roy M Anderson
Journal:  Parasit Vectors       Date:  2022-02-14       Impact factor: 3.876

6.  Improving anthelmintic treatment for schistosomiasis and soil-transmitted helminthiases through sharing and reuse of individual participant data.

Authors:  Martin Walker; Luzia T Freitas; Julia B Halder; Matthew Brack; Jennifer Keiser; Charles H King; Bruno Levecke; Yvonne Ai-Lian Lim; Otavio Pieri; Doudou Sow; J Russell Stothard; Joanne P Webster; Xiao-Nong Zhou; Robert F Terry; Philippe J Guérin; Maria-Gloria Basáñez
Journal:  Wellcome Open Res       Date:  2022-01-05

7.  Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?

Authors:  Jaspreet Toor; Ramzi Alsallaq; James E Truscott; Hugo C Turner; Marleen Werkman; David Gurarie; Charles H King; Roy M Anderson
Journal:  Clin Infect Dis       Date:  2018-06-01       Impact factor: 9.079

8.  Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration.

Authors:  Klodeta Kura; Benjamin S Collyer; Jaspreet Toor; James E Truscott; T Deirdre Hollingsworth; Matt J Keeling; Roy M Anderson
Journal:  Vaccine       Date:  2020-05-14       Impact factor: 3.641

9.  The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni.

Authors:  Jaspreet Toor; Hugo C Turner; James E Truscott; Marleen Werkman; Anna E Phillips; Ramzi Alsallaq; Graham F Medley; Charles H King; Roy M Anderson
Journal:  PLoS Negl Trop Dis       Date:  2018-10-08

10.  Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission.

Authors:  Jaspreet Toor; James E Truscott; Marleen Werkman; Hugo C Turner; Anna E Phillips; Charles H King; Graham F Medley; Roy M Anderson
Journal:  Parasit Vectors       Date:  2019-09-16       Impact factor: 3.876
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.